| # | Drug | Count |
|---|---|---|
| 0 | METFORMIN | 33 |
| 1 | FINASTERIDE | 28 |
| 2 | ASPIRIN | 26 |
| 3 | METFORMIN ER 500 MG | 26 |
| 4 | METFORMIN ER 750 MG | 26 |
| 5 | ASPIRIN 325 MG | 24 |
| 6 | ASPIRIN 81 MG | 24 |
| 7 | ACETAMINOPHEN | 22 |
| 8 | PANTOPRAZOLE | 22 |
| 9 | ATORVASTATIN CALCIUM | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BALSALAZIDE DISODIUM | 2 | 0.0039 |
| 1 | ESMOLOL HYDROCHLORIDE | 1 | 0.0037 |
| 2 | BREXUCABTAGENE AUTOLEUCEL | 8 | 0.0037 |
| 3 | MINERAL OIL, WHITE PETROLATUM | 1 | 0.0035 |
| 4 | 1169 HYDROGEN PEROXIDE SPRAY | 1 | 0.0032 |
| 5 | HYDROGEN PEROXIDE | 1 | 0.0030 |
| 6 | COLLAGENASE CLOSTRIDIUM HISTOLYTICUM | 16 | 0.0029 |
| 7 | MEGNESIUM OXIDE | 1 | 0.0024 |
| 8 | NADOFARAGENE FIRADENOVEC-VNCG | 1 | 0.0019 |
| 9 | IMIPRAMINE HYDROCHLORIDE | 1 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 58 |
| 1 | Corticosteroid [EPC] | 52 |
| 2 | Proton Pump Inhibitor [EPC] | 31 |
| 3 | 5-alpha Reductase Inhibitor [EPC] | 28 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 26 |
| 5 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 22 |
| 6 | Insulin Analog [EPC] | 21 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 20 |
| 8 | beta-Adrenergic Blocker [EPC] | 20 |
| 9 | Loop Diuretic [EPC] | 19 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 1 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 2 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 3 | Live Attenuated Bacillus Calmette-Guerin Immunotherapy [EPC] | 1 | 0.0006 |
| 4 | Contrast Agent for Ultrasound Imaging [EPC] | 3 | 0.0005 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 6 | alpha-1 Adrenergic Agonist [EPC] | 2 | 0.0005 |
| 7 | Typical Antipsychotic [EPC] | 10 | 0.0004 |
| 8 | CD19-directed Chimeric Antigen Receptor [EPC] | 4 | 0.0004 |
| 9 | mu-Opioid Receptor Agonist [EPC] | 1 | 0.0003 |